Literature DB >> 909054

Inactivation of norepinephrine in an isolated vein.

F Brandao.   

Abstract

Canine isolated vein strips were labeled with tritiated norepinephrine (NE). Tritiated NE and its metabolites appearing during spontaneous outflow and during electric stimulation (10 Hz, 100 V, 2 msec, 5 minutes) were determined. The spontaneous outflow of tritiated compounds from the vein contained 90.5% metabolic products of NE, chiefly, the O-methylated and deaminated products (OMDA) and 3,4-dihydroxyphenylglycol (DOPEG). During electric stimulation we observed approximately a 3-fold increase in the outflow of radioactivity, consisting of 39% NE, 25% OMDA and 19% DOPEG. Normetanephrine (NMN) and 3,4-dihydroxymandelic acid represented only 10 and 6%, respectively. Blockade of reuptake of NE into nerve terminals by cocaine did not prevent the appearance of deaminated metabolites in the spontaneous outflow. However, when the vein was electrically stimulated the increase of DOPEG was alomst completely blocked. Blockade of extraneuronal uptake of NE by desoxycorticosterone did not modify significantly the composition of spontaneous outflow. However, desoxycorticosterone caused a marked decrease of NMN and OMDA during electric stimulation. The inhibition of catechol-O-methyltransferase by U-0521 caused a decrease of NMN and OMDA during the spontaneous outflow, and a shift from O-methylation to deamination of NE. During electric stimulation, U-0521 markedly decreased the formation of NMN and OMDA and caused an increase in outflow of NE.

Entities:  

Mesh:

Substances:

Year:  1977        PMID: 909054

Source DB:  PubMed          Journal:  J Pharmacol Exp Ther        ISSN: 0022-3565            Impact factor:   4.030


  14 in total

1.  Plasma dihydroxyphenylglycol and the intraneuronal disposition of norepinephrine in humans.

Authors:  D S Goldstein; G Eisenhofer; R Stull; C J Folio; H R Keiser; I J Kopin
Journal:  J Clin Invest       Date:  1988-01       Impact factor: 14.808

2.  Single pulse stimulation of guinea-pig vas deferens and the presynaptic receptor hypothesis.

Authors:  S Kalsner
Journal:  Br J Pharmacol       Date:  1979-06       Impact factor: 8.739

3.  The influence of uptake2 on the inhibition by unlabelled noradrenaline of the stimulation-evoked overflow of 3H-noradrenaline in rabbit aorta with regard to surface of amine entry.

Authors:  M Henseling
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1983-09       Impact factor: 3.000

4.  Deamination of released 3H-noradrenaline in the canine saphenous vein.

Authors:  T J Verbeuren; P M Vanhoutte
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1982-02       Impact factor: 3.000

5.  A kinetic study of the release of noradrenaline by tyramine.

Authors:  F Brandão; E Rodrigues-Pereira; J G Monteiro; R Davidson
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1981-12       Impact factor: 3.000

6.  Characteristics of tyramine induced release of noradrenaline: mode of action of tyramine and metabolic fate of the transmitter.

Authors:  F Brandão; E Rodrigues-Pereira; J Guilherme Monteiro; W Osswald
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1980-02       Impact factor: 3.000

7.  A study of the adrenoceptor-mediated feedback mechanism by using adrenaline as a false transmitter.

Authors:  S Guimarães; F Brandão; M Q Paiva
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1978-11       Impact factor: 3.000

8.  Differences in the metabolic fate of noradrenaline released by electrical stimulation or by tyramine.

Authors:  F Brandão; J G Monteiro; W Osswald
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1978-10       Impact factor: 3.000

9.  Intra- and extraneuronal metabolism of 5-hydroxytryptamine in the isolated saphenous vein of the dog.

Authors:  M Q Paiva; M Caramona; W Osswald
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1984-01       Impact factor: 3.000

10.  Monoamine oxidase of types A and B in the saphenous vein and mesenteric artery of the dog.

Authors:  M M Caramona
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1982-05       Impact factor: 3.000

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.